हिंदी में पढ़ें

Indian Pharma Companies

Pharma exports FY 2021: Indian made generics see HUGE demand; grows by 18 percent to $24.44 bn

Pharma exports FY 2021: Indian made generics see HUGE demand; grows by 18 percent to $24.44 bn

Sat, Apr 17, 2021

Amid Covid 19 pandemic, Indian pharma sector has stood out. It has grown exponentially in Financial Year 2021. Market Experts are also bullish as far as prospects of Indian Pharma industry is concerned.

FMCG highest paying industry in India: Randstad survey

FMCG highest paying industry in India: Randstad survey

Thu, Apr 06, 2017

"Today employers are cognizant of the fact that the right salary structure is one of the key strategies to attract, engage and retain top talent in the organisation and hence it is important to closely analyse the prevalent salary trends and make course corrections wherever necessary," Randstad India MD & CEO Moorthy K Uppaluri said.

M&A activity to fuel growth for India's pharma sector

M&A activity to fuel growth for India's pharma sector

Mon, Dec 12, 2016

Kaustubh Chaubal, a Moody's Vice President and Senior Analyst said, "The drive for overseas expansion comes amid the consolidation of the global pharmaceutical industry, as drug companies look to boost their product and pipeline diversity, scale and pricing power."

TRENDING NOW

Indian pharma industry facing growth headwinds: ICRA

Indian pharma industry facing growth headwinds: ICRA

Thu, Dec 08, 2016

"In spite of these ongoing challenges, several Indian pharma companies are increasing their R&D spend, targeting pipeline of specialty drugs, niche molecules and complex therapies," ICRA said.

Indian pharma companies better off than global peers: Moody's

Indian pharma companies better off than global peers: Moody's

Fri, Nov 25, 2016

Indian pharmaceutical companies possess stronger financial profiles than global counterparts due to economic growth forecast, solid product pipeline and geographical diversity further adding that merger and acquisitions (M&As) are likely going forward, said Moody's Investors Service.

US DoJ's probe to have limited impact on Indian pharma cos: Fitch

US DoJ's probe to have limited impact on Indian pharma cos: Fitch

Fri, Nov 11, 2016

The ongoing investigation by the US DoJ is likely to have limited impact on Indian pharma companies, said Fitch Ratings on Thursday.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x